investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Healthcare ↓4.41   Biology ↓4.41   Disease: Infectious ↓4.41 «See more»   Disease: Cardiovascular ↓0.11   Biopharma ↑0.96   Medicine ↑0.97

Disease: Cardiovascular stock segment: trending tickers

AMRN Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share -1.56% -1.56% 0 + Country: Ireland, Medicine, Disease: Cardiovascular

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1551182/000155118224000041/0001551182-24-000041-index.htm
10-Q - Eaton Corp plc (0001551182) (Filer)
+ My List
CYTK Cytokinetics, Incorporated - Common Stock 6.46% 6.46% 0 + Medicine, Disease: Cardiovascular

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1061983/000095017024136695/0000950170-24-136695-index.htm
8-K - CYTOKINETICS INC (0001061983) (Filer)
+ My List
ESPR Esperion Therapeutics, Inc. - Common Stock 0.96% 0.96% 0 + Medicine, Biopharma, Disease: Cardiovascular

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1434868/000162828025001672/0001628280-25-001672-index.htm
8-K - Esperion Therapeutics, Inc. (0001434868) (Filer)
+ My List
QTRX Quanterix Corporation - Common Stock -4.41% -4.41% 0 + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1503274/000150327425000006/0001503274-25-000006-index.htm
8-K - Quanterix Corp (0001503274) (Filer)
+ My List
CVRX CVRx, Inc. - Common Stock -1.99% -1.99% 0 + Disease: Cardiovascular, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1376139/000137613925000004/0001376139-25-000004-index.htm
8-K - CVR ENERGY INC (0001376139) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.